GSK Asks 3rd Circ. To Ignore Prior Ruling In Wellbutrin Case

GlaxoSmithKline PLC urged the Third Circuit on Wednesday not to consider its recent ruling in a product liability case over the drug Fosamax when deciding whether or not to revive a...

Already a subscriber? Click here to view full article